Classification of pathogenic or benign status of CNVs detected by microarray analysis

References

• Hehir-Kwa JY, Wieskamp N, Webber C et al. Accurate distinction of pathogenic from benign CNVs in mental retardation. PLoS Comput. Biol.6(4), e1000752 (2010).
   PubMedGoogle Scholar
• Iafrate AJ, Feuk L, Rivera MN et al. Detection of large-scale variation in the human genome. Nat. Genet.36(9), 949–951 (2004).
   PubMed Web of Science ®Google Scholar
• McCarroll SA, Altshuler DM. Copy-number variation and association studies of human disease. Nat. Genet.39, S37–S42 (2007).
   PubMed Web of Science ®Google Scholar
• Sebat J, Lakshmi B, Troge J et al. Large-scale copy number polymorphism in the human genome. Science305, 525–528 (2004).
   PubMed Web of Science ®Google Scholar
• Redon R, Ishikawa S, Fitch KR et al. Global variation in copy number in the human genome. Nature444, 444–454 (2006).
   PubMed Web of Science ®Google Scholar
• Lee JA, Lupski JR. Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron52, 103–121 (2006).
   PubMed Web of Science ®Google Scholar
• Lee C, Iafrate AJ, Brothman AR. Copy number variations and clinical cytogenetic diagnosis of constitutional disorders. Nat. Genet.39, S48–S54 (2007).
   PubMed Web of Science ®Google Scholar
• Choy KW, Setlur SR, Lee C, Lau TK. The impact of human copy number variation on a new era of genetic testing. BJOG117, 391–398 (2010).
   PubMed Web of Science ®Google Scholar
• Miller DT, Adam MP, Aradhya S et al. Consensus statement, chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am. J. Hum. Genet.86, 749–764 (2010).
   PubMed Web of Science ®Google Scholar
• Shen Y, Dies KA, Holm IA et al. Clinical genetic testing for patients with autism spectrum disorders. Pediatrics125, e727–e735 (2010).
   PubMed Web of Science ®Google Scholar
• Lupski JR. Genomic rearrangements and sporadic disease. Nat. Genet.39, S43–S47 (2007).
   PubMed Web of Science ®Google Scholar
• Conrad DF, Pinto D, Redon R et al. Origins and functional impact of copy number variation in the human genome. Nature464, 704–712 (2010).
   PubMed Web of Science ®Google Scholar
• Lachman HM. Copy variations in schizophrenia and bipolar disorder. Cytogenet. Genome Res.123, 27–35 (2008).
   PubMedGoogle Scholar
• Singleton AB, Farrer M, Johnson J et al. α-Synuclein locus triplication causes Parkinson’s disease. Science302, 841 (2003).
   PubMed Web of Science ®Google Scholar
• Chartier-Harlin MC, Kachergus J, Roumier C et al. α-synuclein locus duplication as a cause of familial Parkinson’s disease. Lancet4, 1167–1169 (2004).
   Google Scholar
• Fellermann K, Stange DE, Schaeffeler E et al. A chromosome 8 gene-cluster polymorphism with low human β-defensin 2 gene copy number predisposes to Crohn disease of the colon. Am. J. Hum. Genet.79, 439–448 (2006).
   PubMed Web of Science ®Google Scholar
• Gonzalez E, Kulkarni H, Bolivar H et al. The influence of CCL3L1 gene-containing segmental duplications on HIV-1/AIDS susceptibility. Science307, 1434–1440 (2005).
   PubMed Web of Science ®Google Scholar
• Borozdin W, Graham JM Jr, Bohm D et al. Multigene deletions on chromosome 20q13.13-q13.2 including SALL4 result in an expanded phenotype of Okihiro syndrome plus developmental delay. Hum. Mutat.28, 830 (2007).
   PubMedGoogle Scholar
• Balikova I, Martens K, Melotte C et al. Autosomal-dominant microtia linked to five tandem copies of a copy-number-variable region at chromosome 4p16. Am. J. Hum. Genet.82, 181–187 (2008).
   PubMedGoogle Scholar
• Potocki L, Bi W, Treadwell-Deering D et al. Characterization of Potocki–Lupski syndrome (dup(17)(p11.2p11.2)) and delineation of a dosage-sensitive critical interval that can convey an autism phenotype. Am. J. Hum. Genet.80, 633–649 (2007).
   PubMed Web of Science ®Google Scholar
• Law LW, Lau TK, Fung TY, Leung TY, Wang CC, Choy KW. De novo 16p13.11 microdeletion identified by high resolution array CGH in a fetus with increased nuchal translucency. BJOG116, 339–343 (2009).
   PubMed Web of Science ®Google Scholar
• Choy KW, To KF, Chan AWH, Lau TK, Leung TY. Second-trimester detection of Mowat–Wilson syndrome using comparative genomic hybridization microarray testing. Obstet. Gynecol.115, 462–465 (2010).
   PubMedGoogle Scholar
• Park J, Chen L, Ratnashinge L et al., Deletion polymorphism of UDP-glucuronosyltransferase 2B17 and risk of prostate cancer in African American and Caucasian men. Cancer Epidemiol. Biomarkers Prev.15, 1473–1478 (2006).
   PubMed Web of Science ®Google Scholar
• Karypidis AH, Olsson M, Andersson SO, Rane A, Ekstrom L. Deletion polymorphism of the UGT2B17 gene is associated with increased risk for prostate cancer and correlated to gene expression in the prostate. Pharmacogenomics J.8, 147–151 (2008).
   PubMed Web of Science ®Google Scholar
• Yang TL, Chen XD, Guo Y et al. Genome-wide copy-number-variation study identified a susceptibility gene, UGT2B17, for osteoporosis. Am. J. Hum. Genet.83, 663–674 (2008).
   PubMed Web of Science ®Google Scholar
• Park H, Kim JI, Ju YS et al. Discovery of common Asian copy number variants using integrated high-resolution array CGH and massively parallel DNA sequencing. Nat. Genet.42, 400–405 (2010).
   PubMed Web of Science ®Google Scholar
• Li J, Yang T, Wang L et al. Whole genome distribution and ethnic differentiation of copy number variation in Caucasian and Asian populations. PLoS ONE4, e7958 (2009).
   PubMed Web of Science ®Google Scholar
• Mefford HC, Sharp AJ, Baker C et al. Recurrent rearrangements of chromosome 1q21.1 and variable pediatric phenotypes. N. Engl. J. Med.359, 1685–1699 (2008).
   PubMed Web of Science ®Google Scholar
• Willatt L, Cox J, Barber J et al. 3q29 microdeletion syndrome, clinical and molecular characterization of a new syndrome. Am. J. Hum. Genet.77, 154–160 (2005).
   PubMed Web of Science ®Google Scholar
• de Kovel CG, Trucks H, Helbig I et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain133, 23–32 (2010).
   PubMed Web of Science ®Google Scholar
• Sharp AJ, Mefford HC, Li K et al. A recurrent 15q13.3 microdeletion syndrome associated with mental retardation and seizures. Nat. Genet.40, 322–328 (2008).
   PubMed Web of Science ®Google Scholar
• Miller DT, Shen Y, Weiss LA et al. Microdeletion/duplication at 15q13.2q13.3 among individuals with features of autism and other neuropsychiatirc disorders. J. Med. Genet.46, 242–248 (2009).
   PubMedGoogle Scholar
• Kumar RA, KaraMohamed S, Sudi J et al. Recurrent 16p11.2 microdeletions in autism. Hum. Mol. Genet.17, 628–638 (2008).
   PubMed Web of Science ®Google Scholar
• Weiss LA, Shen Y, Korn JM et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med.358, 667–675 (2008).
   PubMed Web of Science ®Google Scholar
• Coppinger J, Alliman S, Lamb AN, Torchia BS, Bejjani BA, Shaffer LG. Whole-genome microarray analysis in prenatal specimens identifies clinically significant chromosome alterations without increase in results of unclear significance compared with targeted microarray. Prenat. Diagn.29, 1156–1166 (2009).
   PubMed Web of Science ®Google Scholar
• Lu X, Shaw CA, Patel A et al. Clinical implementation of chromosomal microarray analysis, summary of 2513 postnatal cases. PLoS ONE2, e327 (2007).
   PubMed Web of Science ®Google Scholar
• Ashley EA, Butte AJ, Wheeler MT et al. Clinical assessment incorporating a personal genome. Lancet375, 1525–1535 (2010).
   PubMed Web of Science ®Google Scholar
• Girirajan S, Rosenfeld JA, Cooper GM et al. A recurrent 16p12.1 microdeletion supports a two-hit model for severe developmental delay. Nat. Genet.42, 203–209 (2010).
   PubMed Web of Science ®Google Scholar